Praxis Precision Medicines (PRAX) Operating Leases (2019 - 2024)

Praxis Precision Medicines' Operating Leases history runs 6 years deep, the most recent figure standing at $110000.0 for Q4 2024.

• On a quarterly basis, Operating Leases fell 91.96% year-over-year to $110000.0 in Q4 2024; TTM through Dec 2024 was $110000.0, a 91.96% decrease from a year earlier, with the FY2024 full-year figure at $110000.0, down 91.96% from the prior year.
• Operating Leases slipped to $110000.0 in Q4 2024 per PRAX's latest filing, from $436000.0 in the prior quarter.
• Across five years, Operating Leases topped out at $4.2 million in Q3 2021 and bottomed at $110000.0 in Q4 2024.
• The 5-year median for Operating Leases is $1.9 million (2023), against an average of $2.0 million.
• Across the five-year window, Operating Leases soared 2028.79% in 2021 and plunged 91.96% in 2024, its largest moves.
• Year by year, Operating Leases stood at $763000.0 in 2020, then jumped by 358.85% to $3.5 million in 2021, then retreated by 0.03% to $3.5 million in 2022, then plunged by 60.89% to $1.4 million in 2023, then plunged by 91.96% to $110000.0 in 2024.
• Per Business Quant, the three latest PRAX Operating Leases figures stand at $110000.0 (Q4 2024), $436000.0 (Q3 2024), and $755000.0 (Q2 2024).